Showing results (231-240 of 280) with videos related to
Sort By:
Pageof 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Identifying the safety profile of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in anticipation of a phase I clinical trial in patients with recurrent ovarian cancerKellie Matthews, Patricia E Noker, Baohong Tian, et al.Human Gene Therapy|October 14, 2020
Oncolytic Adenovirus Type 3 Coding for CD40L Facilitates Dendritic Cell Therapy of Prostate Cancer in Humanized Mice and Patient SamplesSadia Zafar, Saru Basnet, Inga-Maria Launonen, et al.Annals of Medicine|January 26, 2011
In vivo and in vitro distribution of type 5 and fiber-modified oncolytic adenoviruses in human blood compartmentsSophie Escutenaire, Vincenzo Cerullo, Iulia Diaconu, et al.International Journal of Cancer|March 31, 2015
Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humansSimona Bramante, Johanna K Kaufmann, Ville Veckman, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 28, 2015
Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic AdenovirusKristian Taipale, Ilkka Liikanen, Juuso Juhila, et al.Molecular Therapy Oncolytics|April 28, 2016
Overcoming tumor resistance by heterologous adeno-poxvirus combination therapyMarkus Vähä-Koskela, Siri Tähtinen, Susanna Grönberg-Vähä-Koskela, et al.Frontiers in Immunology|July 21, 2023
An oncolytic adenovirus coding for a variant interleukin 2 cytokine improves response to chemotherapy through enhancement of effector lymphocyte cytotoxicity, fibroblast compartment modulation and mitotic slippageSanteri Pakola, Dafne C A Quixabeira, Tatiana V Kudling, et al.Frontiers in Immunology|August 9, 2021
Adenovirus Armed With TNFa and IL2 Added to aPD-1 Regimen Mediates Antitumor Efficacy in Tumors Refractory to aPD-1Victor Cervera-Carrascon, Dafne C A Quixabeira, Joao M Santos, et al.Frontiers in Immunology|March 31, 2022
Adenovirus Encoding Tumor Necrosis Factor Alpha and Interleukin 2 Induces a Tertiary Lymphoid Structure Signature in Immune Checkpoint Inhibitor Refractory Head and Neck CancerJames H A Clubb, Tatiana V Kudling, Camilla Heiniö, et al.Journal of Virology|December 11, 2012
Resistance to two heterologous neurotropic oncolytic viruses, Semliki Forest virus and vaccinia virus, in experimental gliomaMarkus J V Vähä-Koskela, Fabrice Le Boeuf, Chantal Lemay, et al.Pageof 28